discover its sustainable development report

As Pfizer commits to sustainability in 2020: discover its sustainability report

The biomedical company Pfizer has just presented the sustainable development report in Spain for fiscal year 2020. It summarizes the milestones, plans, actions and projects that have been carried out in the different spheres: scientific, economic, social and environmental.

Sergio Rodríguez, CEO of Pfizer, stressed that “this report shows the main activities carried out by Pfizer during a year marked by the pandemic, showing the company’s commitment to patients, healthcare professionals, our employees and society as a whole. Always in the perspective of sustainable innovation, understood as our way of transforming and building realities through solutions that have a positive impact on society and contribute to the Sustainable Development Goals (SDGs) of Agenda 2030 ”.

In this context of commitment to society, patients and research, the major stages of 2020 were marked by the development of the SARS CoV-2 vaccine in record time. Over the past year, the company has championed the motto ‘Science will win’, reinforcing the idea that science and innovation are fundamental when it comes to addressing what really matters: the health of people. people.

First of all, the people

At Pfizer, one of the most important assets are its professionals. Since its creation and especially in 2020, your health and safety have been a priority for the company. For this reason, faced with the threat of COVID-19, teleworking was quickly implemented – both in central offices and in delegations – and an ‘Exceptional Action Protocol’ was applied. In the case of professionals whose work must be face-to-face to maintain the supply of essential drugs, appropriate measures have been taken to ensure their safety at all times as well. Likewise, despite teleworking, continuous and fluid communication has been maintained with employees, thanks, among other things, to virtual “Town Halls” (company meetings).

Various measures have also been put in place for a possible gradual return to voluntary structures. To this end, the ‘Staged Reoccupation Protocol’ was launched, with mandatory standards for all office staff, in order to protect professionals in a phased return, by providing a “welcome pack” with elements of basis of protection and capacity control through system reporting.

Management constantly strives to make the company a great place to work. And this effort has been recognized by the Top Employer 2020 certificate, making it one of the most attractive organizations to work for in Spain. In addition, it is among the 100 companies that work the best in our country, according to the ranking of Actualidad Econmica 2020 (position 66).

Despite the pandemic, the Diversity Committee has continued to develop activities, such as the “Diversity Decalogue” or “A Café for Equality”, which highlight two of Pfizer’s main pillars: diversity and ‘inclusion. These actions are also reflected in a workforce that stood out in 2020 by its equality with 52% women and 48% men, and 50% – 50% at management level.

Contribute to society

The efforts invested in the fight against COVID-19 are not the only ones that Pfizer has developed over the past year. Thus, nearly 5 million patients in Spain received their treatments in 2020, underlining the raison d’être of the company: innovations that change the lives of patients. In addition to providing innovative medicines, the company has supported patients with projects such as #CrnicosFrentealCovid, with the aim of improving their emotional health, promoted a series of videos and infographics and ensured the home delivery of drugs and telemedicine.

The company is fully engaged in society, multiplying its initiatives with it during the pandemic. During the quarantine months and extending throughout the year, online corporate volunteering began with initiatives such as telephone support for seniors with Adopt a Grandpa, educational talks to young people. with Junior Achievement or Storytelling with Heart with Little Hearts, among others, in which 155 business professionals participated. In addition, Pfizer has made donations to major NGOs across the country to meet the needs of the most vulnerable homes, retirement homes and hospitals. They also received special attention from the company during the most difficult months of the health crisis, providing them with the equipment they needed most urgently, such as thermometers, pulse oximeters, stethoscopes and refrigerators, and strengthening supplies to ensure the supply of essential drugs.

Actions to take care of the environment

In addition to improving people’s lives, Pfizer is committed to protecting the planet and continues to work to have a positive impact on the environment as well. To achieve this, measures have been adopted aimed at removing obstacles to energy efficiency, implementing renewable energies and strategically and long-term planning for energy alternatives.

Among the achievements, the company’s biotechnology plant in Spain, more precisely in San Sebastián de los Reyes (Madrid), has reduced energy consumption by more than 50% (Mwh / million units manufactured) between 2014 and 2020. Following this line, in 2020 an energy and water management system was installed to systematically control its use.

Another of the achievements made and as part of the commitment to minimize greenhouse gas emissions generated in the development of our activities, since 2012 the company, both in the central offices and in the delegations, has succeeded in reduce CO2 emissions by 32.8%. Likewise, Pfizer plans to set up a photovoltaic power plant in the biotech plant between 2021 and 2022, capable of generating 2,700 MWh, thereby reducing CO2 emissions by around 700 tonnes.

As part of the circular economy strategy, Pfizer’s working philosophy is based on the principles of production-use-recycling. They thus join the “Pfizer Forest”, a business project that seeks to reduce our impact on nature.

SDGs: Sustainable innovation for a better world

The concept of sustainable innovation of the company aims to generate value for people and, therefore, to contribute to the achievement of the Sustainable Development Goals (SDGs) set by the UN for the year 2030.

In this sense, Pfizer is particularly focusing its work and efforts on SDG 3: “Ensure healthy lives and promote well-being for all at all ages”. In addition, it also contributes to other SDGs, such as gender equality, decent work and economic growth, industry, innovations and infrastructure; Responsible production and consumption, and Alliances to achieve goals.

“We are currently in the process of further integrating our ‘Innovations that change the lives of patients’ objective with our environmental, social and governance (ESG) strategy to better understand and meet the needs of patients, collaborators, partners, shareholders and the communities we serve. », Underlined the CEO of Pfizer Spain.

For more information, the Pfizer Sustainability Report in Spain for FY2020 can be downloaded at

Pfizer, innovations that change patients’ lives

Pfizer, as a biomedical company working to improve human health, is dedicated to the development of innovative therapies and vaccines to cure and prevent diseases or relieve their symptoms. With a history of over 170 years, Pfizer maintains its commitment to society and engages in R&D to meet the medical needs of today and tomorrow. The advancement of science and technology, as well as its medical application, requires working with everyone involved to maximize the drug portfolio and for pharmaceutical innovation to reach everyone who needs it quickly, at a affordable, reliable and transparent. , in accordance with the highest standards of quality and safety.

* If you found this article interesting, we encourage you to follow us on TWITTER and subscribe to our DAILY NEWSLETTER.


semidedicated hosting
Back to top button